Compare ECF & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ECF | KRMD |
|---|---|---|
| Founded | 1986 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.2M | 192.5M |
| IPO Year | N/A | 2019 |
| Metric | ECF | KRMD |
|---|---|---|
| Price | $12.70 | $4.49 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.50 |
| AVG Volume (30 Days) | 26.1K | ★ 153.7K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 6.42% | N/A |
| EPS Growth | N/A | ★ 53.85 |
| EPS | ★ 0.46 | N/A |
| Revenue | N/A | ★ $41,127,366.00 |
| Revenue This Year | N/A | $20.32 |
| Revenue Next Year | N/A | $17.37 |
| P/E Ratio | $27.61 | ★ N/A |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $10.16 | $2.91 |
| 52 Week High | $13.85 | $6.61 |
| Indicator | ECF | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 42.30 | 62.63 |
| Support Level | $12.55 | $3.84 |
| Resistance Level | $13.17 | $4.68 |
| Average True Range (ATR) | 0.27 | 0.19 |
| MACD | -0.06 | 0.05 |
| Stochastic Oscillator | 5.33 | 91.67 |
Ellsworth Growth and Income Fund Ltd operate as a closed-end, diversified management investment company. Its investment objective is to provide income and the potential for capital appreciation, which objectives the Fund considers to be relatively equal over the long term due to the nature of the securities in which it invests. The company invests in convertible and equity securities. It invests in various sectors, such as healthcare, financial services, computer software and services, energy and utilities, real estate investment trusts, semiconductors, telecommunications, business services, food and beverage, consumer products, transportation, consumer services among others.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.